Abstract:Bradley Beauvais, 1 Zachary Whitaker, 2 Forest Kim, 2 Benjamin Anderson 3 1 Texas State University, San Marcos, TX, USA; 2 Baylor University, Waco, TX, USA; 3 Colorado Hospital Association, Greenwood Village, CO, USA Correspondence: Bradley Beauvais, Tel +210 627-1078, Email Introduction: Hospital readmissions have been associated with adverse outcomes and elevated financial costs to patients, families, and hospitals across the United States. Historically, nearly 20% of all Medicare discharges had a readmission within 30 days. In an effort to address this issue, the Affordable Care Act (ACA) established the Hospital Readmission Reduction Program (HRRP) in 2012 to positively influence readmissions associated with acute myocardial infarction, chronic obstructive pulmonary disease, heart failure, pneumonia, coronary artery bypass graft surgery, and total hip and/or knee arthroplasty. However, as recently as 2018, there were still 3.8 million 30-day all-cause adult hospital readmissions, with a 14% readmission rate and an average readmission cost of $15,200. The ACA also produced the Hospital Value-Based Purchasing (HVBP) program with the stated intent to (1) reduce mortality and complications, (2) reduce healthcare-associated infections, (3) increase patient safety, (4) improve the patient experience, and (5) increase efficiency and reduce costs. Given the costs and quality implications of an average readmission, it is logical to believe that HVBP eligible hospitals are simultaneously seeking to meet the goals of both programs. However, to date, no studies have examined if that is the case. Thus, in this study, we seek to determine if HVBP eligible hospitals are associated with a reduction in the core set of HRRP readmission rates better than the facilities that are not eligible for the HVBP program. Methods: Hospital-level data from calendar year 2019 for 3,276 short-term acute care hospitals in the United States were evaluated using multivariate regression analysis to examine the readmission rate performance between 2,719 HVBP eligible hospitals and 557 ineligible hospitals. Results: Our six separate multivariable linear regressions revealed a statistically significant and positive association between HVBP participation and readmission rates after controlling for numerous organizational, clinical complexity, and environmental factors. In each case, the magnitude of the positive directional association is moderate, ranging from and increase of +0.19% (pneumonia readmissions) to as high as +0.37% (all cause readmissions) for HVBP eligible hospitals. When considered in the context of the average number of discharges in our data set (x- = 9570), a third of a percent increase from the average 15.56% all cause readmissions to 16.08% in HVBP eligible hospitals equates to 50 additional readmissions annually (9570 × 15.56% = 1,489 vs 9570 × 16.08% = 1,539). At an average cost of 760,000. Discussion: The fact that there is a positive association between HVBP participating hospitals and readmissions at all, and that the same effect appears to be persistent across all dependent measures is concerning. One would logically expect hospitals that are focused on quality-based care to thoroughly care for individuals in order for them to not be readmitted to the hospital. The results provided do not necessarily prove that either program is not working. But they also do not confirm that the HVBP and HRRP programs are working together and accomplishing what they were originally designed to do: improve patient care and lower health-care costs. Keywords: hospitals, value-based care, HVBP, readmissions, HRRP In the United States, health care is a $4 trillion industry (2020) and currently accounts for 17.7% of US Gross Domestic Product (GDP), and nearly a third of this cost (32.8%) is directly attributable to hospital care. 5 The trajectory of health-care cost inflation shows little sign of slowing down as the health-care share of GDP is expected to rise to 19.7% by 2028. 6 A significant portion of the expense incurred within the US healthcare system can be attributed to hospital readmission. 1,2 In addition, over $52.4 billion is spent annually to care for patients that were readmitted to the hospital within 30 days for a previously treated condition. 7,8 As recently as 2018, there were 3.8 million 30-day all-cause adult hospital readmissions, with a 14% readmission rate and an average readmission cost of $15,200. 3 The 111th United States Congress and President Barack Obama sought to address these issues wit -Abstract Truncated-

Medicare's hospital readmissions reduction program and the rise in observation stays

Accounting for the Growth of Observation Stays in the Assessment of Medicare's Hospital Readmissions Reduction Program

What Is an Observation Stay? Evaluating the Use of Hospital Observation Stays in Medicare

Trends in 30-Day Readmission Rates for Medicare and Non-Medicare Patients in the Era of the Affordable Care Act

Association of the hospital readmissions reduction program implementation with readmission and mortality outcomes in heart failure

Medicare's Hospital Readmission Reduction Program reduced fall-related health care use: An unexpected benefit?

Readmissions performance and penalty experience of safety-net hospitals under Medicare’s Hospital Readmissions Reduction Program

Impact of Hospital Readmissions Reduction Program Policy on 30-Day and 90-Day Readmissions in Patients With Acute Myocardial Infarction: A 10-Year Trend From the National Readmissions Database

Hospitals serving nursing home residents disproportionately penalized under hospital readmissions reduction program

Regression to the Mean in the Medicare Hospital Readmissions Reduction Program

Impact of time from discharge to readmission on outcomes: an observational study from the US National Readmission Database

The Long-Term Effect of Financial Penalties on 30-Day Hospital Readmission Rates

Hospital, patient, and local health system characteristics associated with the prevalence and duration of observation care

What is the impact of a clinically related readmission measure on the assessment of hospital performance?

Is the Hospital Value-Based Purchasing Program Associated with Reduced Hospital Readmissions?

Trends in 30- and 90-Day Readmission Rates for Heart Failure

Care Quality for Patients with Chronic Obstructive Pulmonary Disease in the Readmission Penalty Era

Association of Insurance Type with Inpatient Surgical 30-day Readmissions, Emergency Department Visits/Observation Stays, and Costs

Impact of a Post-Discharge Integrated Disease Management Program on COPD Hospital Readmissions

Association of Diagnosis Coding With Differences in Risk-Adjusted Short-term Mortality Between Critical Access and Non-Critical Access Hospitals

Hospital Readmission after Post-acute Care at Different Settings: Estimation using the Propensity Score Matching Method